Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality

Pohl, R. Vincent (2018): Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality.

Abstract

Mortality due to opioid overdoses has been growing rapidly in the U.S., with some states experiencing much steeper increases than others. Legalizing medical cannabis could reduce opioid-related mortality if potential opioid users substitute towards cannabis as a safer alternative. I show, however, that a substantial reduction in opioid-related mortality associated with the implementation of medical cannabis laws can be explained by selection bias. States that legalized medical cannabis exhibit lower pre-existing mortality trends. Accordingly, the mitigating effect of medical cannabis laws on opioid-related mortality vanishes when I include state-specific time trends in state-year-level difference-in-differences regressions.

• Item Type: MPRA Paper
• Language: English
• Keywords: medical cannabis laws, opioid overdose mortality, difference-in-differences, group-specific time trends
• Subjects: C - Mathematical and Quantitative Methods > C2 - Single Equation Models ; Single Variables > C23 - Panel Data Models ; Spatio-temporal Models; I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior; I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health; K - Law and Economics > K3 - Other Substantive Areas of Law > K32 - Environmental, Health, and Safety Law

References

Alpert, Abby, David Powell, and Rosalie Liccardo Pacula. 2017. “Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids.” NBER Working Paper 23031.

Anderson, D. Mark, Benjamin Hansen, and Daniel I. Rees. 2013. “Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption.” The Journal of Law and Economics 56 (2):333–369.

Bachhuber, Marcus A., Brendan Saloner, Chinazo O. Cunningham, and Colleen L. Barry. 2014. “Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010.” JAMA Internal Medicine 174 (10):1668–1673.

Bradford, A. C. and W. D. Bradford. 2016. “Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D.” Health Affairs 35 (7):1230–1236.

Bradford, Ashley C. and W. David Bradford. 2017. “Medical Marijuana Laws May Be Associated With A Decline In The Number Of Prescriptions For Medicaid Enrollees.” Health Affairs 36 (5):945–951.

Bradford, Ashley C., W. David Bradford, Amanda Abraham, and Grace Bagwell Adams. 2018. “Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.” JAMA Internal Medicine 178 (5):667–672.

Buchmueller, Thomas C. and Colleen Carey. 2018. “The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare.” American Economic Journal: Economic Policy 10 (1):77–112.

Card, David and Alan B. Krueger. 1994. “Minimum Wages and Employment: A Case Study of the Fast-Food Industry in New Jersey and Pennsylvania.” American Economic Review 84 (4):772–793.

Chapman, Susan A., Joanne Spetz, Jessica Lin, Krista Chan, and Laura A. Schmidt. 2016. “Capturing Heterogeneity in Medical Marijuana Policies: A Taxonomy of Regulatory Regimes Across the United States.” Substance Use & Misuse 51 (9):1174–1184.

Chriqui, Jamie F., Rosalie L. Pacula, Duane C. McBride, Deborah A. Reichmann, Curtis J. Vanderwaal, and Yvonne M. Terry-McElrath. 2002. Illicit Drug Policies: Selected Laws from the 50 States. Berrien Springs, MI: Andrews University.

Chu, Yu-Wei Luke. 2015. “Do Medical Marijuana Laws Increase Hard-Drug Use?” The Journal of Law and Economics 58 (2):481–517.

Dave, Dhaval M., Anca M. Grecu, and Henry Saffer. 2017. “Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse.” NBER Working Paper 23537.

Doleac, Jennifer L and Anita Mukherjee. 2018. “The Moral Hazard of Lifesaving Innovations: Naloxone Access, Opioid Abuse, and Crime.”

Evans, Williams N., Ethan Lieber, and Patrick Power. 2018. “How the Reformulation of OxyContin Ignited the Heroin Epidemic.” NBER Working Paper 24475.

Garin, Julio, R. Vincent Pohl, and Rhet A. Smith. 2018. “Medical Cannabis Dispensaries May Lower Opioid and Heroin Overdose Mortality.”

Hollingsworth, Alex, Christopher J. Ruhm, and Kosali Simon. 2017. “Macroeconomic Conditions and Opioid Abuse.” NBER Working Paper 23192.

Li, Guohua, Joanne E. Brady, Barbara H. Lang, James Giglio, Hannah Wunsch, and Charles DiMaggio. 2014. “Prescription Drug Monitoring and Drug Overdose Mortality.” Injury Epidemiology 1 (9):1–8.

Mallatt, Justine. 2017. “The Effect of Prescription Drug Monitoring Programs on Opioid Prescriptions and Heroin Crime Rates.”

Meinhofer, Angelica. 2017. “Prescription Drug Monitoring Programs: The Role of Asymmetric Information on Drug Availability and Abuse.” American Journal of Health Economics online first.

Pacula, Rosalie L., Anne E. Boustead, and Priscilla Hunt. 2014. “Words Can Be Deceiving: A Review of Variation among Legally Effective Medical Marijuana Laws in the United States.” Journal of Drug Policy Analysis 7 (1):1–19.

Pacula, Rosalie L., Jamie F. Chriqui, Deborah A. Reichmann, and Yvonne M. Terry- McElrath. 2002. “State Medical Marijuana Laws: Understanding the Laws and Their Limitations.” Journal of Public Health Policy 23 (4):413–439.

Pacula, Rosalie L., David Powell, Paul Heaton, and Eric L. Sevigny. 2015. “Assessing the Effects of Medical Marijuana Laws on Marijuana Use: The Devil Is in the Details.” Journal of Policy Analysis and Management 34 (1):7–31.

Pardo, Bryce. 2017. “Do More Robust Prescription Drug Monitoring Programs Reduce Prescription Opioid Overdose?: Prescription Drug Monitoring and Opioid Overdoses.” Addiction 112 (10):1773–1783.

Patrick, S. W., C. E. Fry, T. F. Jones, and M. B. Buntin. 2016. “Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.” Health Affairs 35 (7):1324–1332.

Paulozzi, Leonard J., Edwin M. Kilbourne, and Hema A. Desai. 2011. “Prescription Drug Monitoring Programs and Death Rates from Drug Overdose.” Pain Medicine 12 (5):747– 754.

Powell, David, Rosalie Liccardo Pacula, and Mireille Jacobson. 2018. “Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?” Journal of Health Economics 58:29–42.

Quinones, Sam. 2015. Dreamland: The True Tale of America’s Opiate Epidemic. New York: Bloomsbury.

Rees, Daniel I., Joseph J. Sabia, Laura M. Argys, Joshua Latshaw, and Dhaval Dave. 2017. “With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths.” NBER Working Paper 23171.

Ruhm, Christopher J. 2018. “Deaths of Despair or Drug Problems?” NBER Working Paper 24188.

Smith, Rhet A. 2017. “The Effects of Medical Marijuana Dispensaries on Adverse Opioid Outcomes.”

Wen, Hefei and Jason M. Hockenberry. 2018. “Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.” JAMA Internal Medicine 178 (5):673–679.